A 360° View of the News.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Mother's Day
Pope Leo XIV
Artificial Intelligence
Donald Trump
Social Media
Democratic Party
Baseball
Pope Francis
Republican Party
Golf
Trade
US Politics
Published • loading... • Updated

FDA proposes overhaul of fast-track process for cancer meds

Summary by Ground News
FDA proposes randomized controlled trials instead of widely used "single-arm studies" The agency's accelerated approval process has drawn fire for the way it allows manufacturers to launch products based on preliminary evidence and charge high prices before they complete trials. The comment period on the guidance runs through May 26.

1 Articles

All
Left
1
Center
Right
AxiosAxios
Lean Left

FDA proposes overhaul of fast-track process for cancer meds

The Food and Drug Administration is eyeing policy changes that could make drugmakers conduct more stringent trials to win fast-track approvals of cancer drugs.

·Washington, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Axios broke the news in Washington, United States on Tuesday, March 28, 2023.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cancer

Cancer

FDA

FDA

News
For You
SearchBlindspotLocal